Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00281229 · ClinicalTrials.gov registry record
T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 481
- Enrollment target
NCT00281229: Completed study, sponsored by University of Michigan.
NCT00281229 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 481 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00281229 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 481 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the lungs of individuals with chronic obstructive pulmonary disease (COPD) contain resident memory T lymphocytes that can produce a combination of cytokines that induce the symptoms of an acute exacerbation of COPD (AE-COPD). Specifically, the study will determine cell-surface receptors of lung T cells in comparison with blood T cells from the same subject, and will examine anti-CD3-activated blood or lung T cells for interleukin (IL)-6 and interferon-gamma production in response to IL-18, and for IL-17A production in response to recombinant IL-23.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 481 participants |
| Start Date | 2005-09 |
| Est. Completion | 2015-01 |
What the finished NCT00281229 record still lists
NCT00281229 is an observational study that tracks outcomes without assigning an intervention. The registered 481 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00281229 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00281229 about?
NCT00281229 is a clinical study titled "T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease". The purpose of this study is to determine whether the lungs of individuals with chronic obstructive pulmonary disease (COPD) contain resident memory T lymphocytes that can produce a combination of cytokines that induce the symptoms of an acute exacerbation of COPD (AE-COPD). Specifically, the study ...
What is the current status of trial NCT00281229?
This trial is currently completed. The enrollment target is 481 participants. The study started on 2005-09. Estimated completion is 2015-01.
Who is sponsoring clinical trial NCT00281229?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04449458 · 482 participants · NA
The Positively Quit Trial for Smoking Cessation
- NCT07079631 · 482 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia